Want to join the conversation?
Pharmaceutical company $ABT said that the FDA has approved the first in a new category of intraocular lenses called Tecnis Symfony for the treatment of cataracts. These lenses provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia, also known as farsightedness.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?